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Abstract 
5-year survival rate for childhood acute lymphoblastic leukemia (ALL) has risen to approximately 90%, 
yet the causal disease pathway is still poorly understood. Evidence suggests multiple ‘hits’ are required 
for disease progression; an initial genetic abnormality followed by additional secondary ‘hits’. It is 
plausible that environmental influences may trigger these secondary hits, and with the peak incidence 
of diagnosis between 2-5 years of age, early life exposures are likely to be key. DNA methylation can 
be modified by many environmental exposures and is dramatically altered in cancers, including 
childhood ALL. Here we explore the potential that DNA methylation may be involved in the causal 
pathway toward disease by acting as a mediator between established environmental factors and 
childhood ALL development.   
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Genetics of acute lymphoblastic leukemia  
Acute lymphoblastic leukemia (ALL) is the most 
common form of childhood leukemia. ALL is a 
cancer of the blood and bone marrow which 
arises from genetic abnormalities which can 
occur in utero. These abnormalities lead to the 
malignant transformation of lymphocyte 
progenitor cells into leukaemic cells of the B-
cell and T-cell lineages [1]. Childhood ALL is a 
heterogeneous disease. Most cases are 
definable by large-scale chromosomal 
translocations/aberrations, resulting in distinct 
biological subtypes, each with individual 
characteristics. Patients are usually organised 
into subtypes depending on their cellular 
immunophenotype and recurrent cytogenetic 
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aberrations. The most prognostically 
important subtypes include T-ALL, high 
hyperdiploidy (51-65 chromosomes), E2A-
PBX1, BCR-ABL, ETV6-RUNX1 (TEL-AML1), and 
MLL rearrangements [2]. The time frame 
between the emergence of genetic 
abnormalities and disease onset, and the 
frequency of children born with abnormalities 
compared with the number of children who go 
on to develop ALL, suggests multiple ‘hits’ are 
required for the manifestation of disease [3]. A 
recognized leukaemic clone with the TEL-AML1 
fusion gene has been found in 1% of newborn 
babies by screening neonatal blood spots [4]. 
This frequency is a 100 times higher than the 
incidence of ALL defined with this fusion gene 
later in childhood [5]. Diagnosis of ALL is 
variable with peak incidences between two 
and five years of age [4], suggesting an 
undefined period of latency whereby 
additional abnormalities are acquired for 
malignant transformation to occur. 
Furthermore, identical twins with the TEL-
AML1 fusion gene showed only a 10% 
concordance rate further supporting the 
concept that additional events or ‘hits’ are 
needed for the full transformation to leukemia, 
or specifically ALL development [4].  
DNA methylation & ALL  
DNA methylation was first reported as a 
regulatory mechanism influencing gene 
expression in 1975 by Holliday and Pugh, and 
Riggs [6]. Methylation of cytosine residues 
located within CpG dinucleotides across the 
genome is an epigenetic modification which 
plays a crucial role in the creation of cellular 
identity by influencing gene expression during 
early development [7]. Methyl groups are 
added to DNA by DNMTs. This group of 
enzymes are responsible for the  establishment 
of methylation patterns during development 
(DNMT3A, DNMT3B, and their co-factor 
DNMT3-like) and the maintenance of 
methylation during replication (DNMT1) [8]. 
The majority of mammalian CpG sites are 
methylated but CpG islands (CGIs) significantly 
deviate from the regular genomic pattern; CGIs 
are GC and CpG rich, and predominantly non-
methylated [9]. Hyper-methylation of CpG 
sites occur in a non-random tissue specific 
manner, and when this occurs at promoter 
sites it can block gene transcription. This 
mechanism of gene regulation plays an 
important role in tissue differentiation, X-
chromosome inactivation, genomic imprinting, 
and suppression of transposable elements [1].  
Cancer is now recognised as an epigenetic 
disease [10]. The cancer cell genome 
undergoes dramatic shifts in the pattern of 
genomic methylation, including genome wide 
hypomethylation in conjunction with local 
areas of hypermethylation, often centred on 
promoter associated CGIs. One known 
disruptive mechanism in cancer is the silencing 
of tumour suppressor genes, such as p16INK4a, 
via hypermethylation of their promotor 
associated CGIs [10]. Aberrant CpG 
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methylation in cancer cells can have extensive 
effects on gene regulation, which can affect 
cell function and lead to adverse outcomes if 
genes such as tumour suppressors and others 
involved in important cellular processes (DNA 
repair, apoptosis, drug-detoxification, and 
many more critical genes) are inactivated.  
One of the first studies to investigate the DNA 
methylome of childhood ALL focused on the 
most common subtypes, ETV6/RUNX1 and 
high hyperdiploidy [11]. A microarray platform 
comprising of 28226 CGIs, cDNA microarrays, 
and array comprehensive genomic 
hybridisation (CGH) were used to investigate 
altered global methylation, correlation 
between hypermethylation and gene 
expression, and detection of genomic 
imbalance, respectively. The three most 
common groups of genes which displayed 
hypermethylation and resultant under-
expression were transcription regulators, 
regulators of apoptosis, and cell signalling 
genes, all possible targets for future 
treatments.  
An array designed to investigate DNA 
methylation patterns of 416 genes in cells from 
401 diagnostic ALL samples included CpG sites 
2kb upstream and 1kb downstream of 
transcription start sites [12]. CpG sites located 
outside of CGIs showed a greater variation and 
overall methylation compared to CpG sites 
located within CGIs. These sites may offer an 
alternate transcription start site, and therefore 
alterations in DNA methylation at these CpG 
sites may affect gene expression. This notion 
was supported by a notable inverse correlation 
between CpG site methylation and gene 
expression. Methylation profiles of forty genes 
were also identified as consistently and 
accurately discriminating between four 
subtypes of B-cell precursor (BCP) ALL, and 
DNA methylation levels of 20 individual genes 
predicted relapse.    
Integrated genetic and epigenetic analysis of 
childhood ALL has provided evidence for 
alterations in DNA methylation playing a key 
role in leukemogenesis [13]. Figueroa et al. 
[13] analysed 137 B-cell and 30 T-cell lineage 
childhood ALL samples, and 19 B-cell samples 
from healthy children. Genome-wide cytosine 
methylation profiling analysis was carried out 
using the HpaII tiny fragments enrichment by 
ligation-mediated PCR (HELP) assay. A high 
degree of agreement was found between 
epigenetic subtypes and genetic subtypes. 
Furthermore a core set of epigenetically 
deregulated genes were common to all cases, 
suggesting their involvement in a central role 
in the initiation or maintenance of lymphoid 
transformation.  
Nordlund et al. [1] used the Infinium 
HumanMethylation450 Beadchip (450K 
BeadChip) to investigate genome wide DNA 
methylation signatures in paediatric ALL, and 
were able to characterise different groups 
through methylation pattern changes and 
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these corresponded closely to the known 
cytogenetic subtypes. They found that the 
methylomes of ALL cells shared 9402 
predominantly hypermethylated CpG sites 
compared to controls, these observations 
were seen across all ALL subtypes. A unique set 
of hypo/hyper-methylated CpGs were 
identified for each cytogenetic subtype. 
Subtype specific altered methylation strongly 
associated to gene expression in the promotor 
and enhancer regions. Six thousand six 
hundred and twelve CpG sites were also found 
predominantly hypermethylated in ALL cells at 
relapse compared to matched samples at 
diagnosis. Although a significant association 
between methylation at diagnosis and 
subsequent relapse was only seen in the 
ETV6/RUNX1 subtype. These findings were 
followed up by developing methodology for 
DNA methylation profiling for paediatric ALL 
[14], enabling the clarification of a 
heterogeneous group of cytogenetically 
undefined ALL patients. Gabriel at al [15] were 
unable to predict ALL patient relapse using the 
450K BeadChip or to replicate the ETV6/RUNX1 
relapse signature identified by Nordlund et al. 
However, this study did reproduce the 
correlation Nordlund at al [1] identified 
between genome wide DNA methylation 
pattern and the different cytogenetic 
subgroups, and validated many of the 
cytogenetic specific markers. This indicates 
that subtype specific patterns of altered 
methylation are consistent across different 
cohorts.  
Epigenetic remodelling of paediatric B-cell ALL 
(B-ALL) has been investigated in reference to 
normal B-cell precursors [16] using whole-
genome bisulfite sequencing and 450k 
BeadChips. The analysis of 227 B-ALL patients 
from the California Childhood Cancer Study 
revealed two tracks of epigenetic alterations. 
De novo methylation occurred at small 
functional compartments e.g. CGIs, promotors, 
TF-binding sites and DNase hyper sensitive 
sites. Whilst demethylation in subsets of 
leukemia were apparent in large inter-
compartmental backbones, although this 
change was subtle. CGIs were de novo 
methylated throughout promotors and bodies 
rather than gene bodies, a suggested crude yet 
potent way of gene silencing. In regions with 
hypermethylation there was an enrichment of 
CTBP2 sites, suggesting that CTBP2 may recruit 
factors which drive the observed 
hypermethylation.  
MIRA-seq has also been utilised to identify 
differentially methylation regions (DMR) in ALL 
compared to healthy precursor B-cells isolated 
from cord blood, with a total of 15492 regions 
losing methylation, and 9790 regions gaining 
methylation [17]. The majority of DMRs 
associated with a CGI were hypermethylated, 
although roughly 80% of the total DMRs were 
identified in intronic or intergenic regions. 
Functional gene analysis revealed that 70% of 
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the intergenic DMRs were associated with 
functional regulatory elements. Genes which 
are regulated by DNA methylation and provide 
a selective growth advantage to cancer have 
been named epi-driver genes [18], and provide 
insight into the progression of cancer as well as 
being valuable therapeutic targets. These 
findings elaborate and strengthen previous 
research proving evidence for alterations in 
DNA methylation in ALL and their possible 
implications in the causal pathway, disease 
progression and relapse [1, 12, 19, 20]. These 
alterations in DNA methylation are an 
invariable feature of development of ALL and 
environmental factors that disrupt DNA 
methylation patterns could lead to increased 
risk to all subtypes of ALL, or increased risk of 
specific subtypes depending on the genomic 
regions affected. 
DNA methylation & the environment  
DNA methylation is susceptible to change 
through environmental influences [9], and it 
has been suggested that it may provide a 
lifetime record of a person’s exposure to 
environmental exposures [21]. Reports from 
the literature provide evidence that a range of 
environmental exposures can influence DNA 
methylation [22, 23]. There are several 
avenues through which environment has the 
potential to influence methylation patterns, 
illustrated in Figure 1.   
 
Figure 1. Overview of pathways by which environmental factors may influence DNA methylation. 
Environment may influence DNA methylation at any time in the life course, however critical windows 
exist (i.e. during early development in utero and early life known as developmental programming) 
whereby these factors may have a more profound influence. Environmental factors may affect DNA 
methylation directly (white arrows) and indirectly (grey arrows). Direct pathways include a) altered 
substrate availability i.e. of the universal methyl donor, SAM which is a substrate used to methylate 
DNA; b) altering the expression of genes responsible for maintaining or establishing methylation 
patterns (i.e. DNA methyltransferase (DNMTs) enzymes); c) altering other regulatory epigenetic 
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mechanisms which influence methylation patterns. Indirect pathways include a) altering expression 
of genes responsible for substrate availability (i.e. genes involved in OCM which is responsible for the 
generation of SAM); b) altering other epigenetic factors which may influence substrate availability 
through further gene expression changes. Genetic factors (indicated by dashed black arrows) are also 
likely to affect substrate availability, gene expression and other epigenetic factors, and may interact 
with environment to influence DNA methylation levels. OCM: One carbon metabolism; SAM: S-
adenosylmethionine. 
In the early stages of life, epigenetic marks 
undergo radical changes, and there appears to 
be two main cycles of reprogramming in 
mammalian embryos. The first cycle occurs 
following fertilization, when the DNA 
methylation marks of the parental gametes are 
erased in two waves of demethylation. This is 
followed by a second cycle of remethylation 
during germ cell development, creating a more 
developmentally restricted epiblast [24, 25]. 
As this developmental stage is therefore key in 
the establishment of epigenetic marks that will 
be passed on through the life course during 
mitosis, early life environmental exposures 
which may influence the establishment of 
these marks have the potential to affect gene 
expression in later life [26]. Indeed mouse 
studies which have utilised the Agouti variable 
yellow (Avy) metastable epiallele as an 
epigenetic biosensor for environmental effects 
on the fetus have demonstrated that maternal 
supplementation during pregnancy with 
methyl donors, genistein and ethanol can 
influence methylation at this gene locus. This 
change in methylation was concomitant with 
altered phenotypic outcomes [27-29], 
providing evidence supporting the hypothesis 
that environmental influences on the 
epigenome during early life can affect adult 
phenotype. Waterland et al. [30] identified 
metastable epiallele loci in the human genome 
and subsequently observed elevated DNA 
methylation of those loci in individuals 
conceived during the nutritionally challenged 
rainy season in rural Gambia. Maternal 
aflatoxin B1 exposure, has also been observed 
to alter DNA methylation of 71 loci when 
measured utilising 450K BeadChip platform in 
white blood cells from infants in the Gambia 
[31], which the authors suggest may be 
relevant to aflatoxin-related child stunting. 
Furthermore, the effect of dietary exposure 
during gestation was evaluated using a quasi-
experimental setting of the Dutch Famine of 
1944-45 [32]. Methylation levels were 
measured using the 450K BeadChip on whole 
blood samples from 422 individuals roughly 
aged 59 years. Famine exposure during the 
first ten weeks of gestation was associated 
with altered methylation at various CpG sites 
linked to genes which are involved in growth, 
development, and metabolism. Within the 
Dutch Famine cohort increased coronary heart 
disease, raised lipids, altered clotting and more 
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obesity have been reported in association with 
exposure to famine in early gestation [33]. 
Taken together this may suggest a critical time 
window of susceptibility to change in DNA 
methylation via environmental influences.   
Identification of exposures associated 
with risk of developing childhood ALL 
Literature searches were carried out to identify 
exposures associated with ALL risk (listed in 
Table 1) using the PubMed and ScienceDirect 
databases (1987-2015). An initial search was 
performed to identify reviews discussing ALL 
and possible causes or associations with an 
increased risk. This created a list of possible 
risk factors for ALL and key words (Box 1) were 
used for a more rigorous investigation of the 
literature to confirm the association between 
risk factor and leukemia development. There 
were no language restrictions imposed. In 
addition, the lists of references in previous 
studies (including reviews) were also screened 
to identify additional relevant studies. We 
subsequently investigated the literature for 
evidence of variation in DNA methylation in 
response to the exposures identified by the 
above analysis as having published evidence 
linking them to ALL risk. These further 
literature searches were carried out using the 
PubMed and ScienceDirect databases (1987-
2015). The key words used were “DNA 
methylation” along with key words stated for 
each of the exposures identified (Box 1). Each 
individual search produced varying amounts of 
literature supporting an association between 
an exposure and changes in methylation 
patterns. Duplicate publications retrieved from 
different databases were removed. Where 
large numbers of publications were found, 
human epidemiological studies using array 
based technologies to analyse DNA 
methylation were discussed as a priority over 
animal or cell line studies using site specific 
methods to measure DNA methylation.   
Box 1. Key words used to identify literature on specific environmental factors associated with ALL 
risk. 
Key words 
Leukemia, acute lymphoblastic, radiation, smoking, alcohol, folate, folic acid, iron, coffee, 
caffeine, herbicides, pesticides, household chemicals, chemicals, household paints, paints, child 
care, day care, breast feeding, birth weight, infection history, infection, virus, and bacterial. 
Environmental factors associated with 
ALL risk  
A number of in utero and early childhood 
exposures have been implicated in the 
aetiology of childhood ALL [34]. These include 
8 
 
birth weight, breast feeding, infection history, 
childcare/ day care attendance, smoking, 
alcohol, caffeine, folic acid, iron, radiation, 
household chemicals, paints, pesticides, and 
herbicides (see Table 1). Whilst these listed 
exposures have all been observationally 
associated with increased risk of ALL, the 
weight of supporting evidence for the role of 
each exposure in the aetiology of childhood 
ALL varies. Whilst there is fairly strong 
evidence in support of the role of some 
exposures (such as day care attendance, 
radiation, folic acid, smoking, and alcohol) for 
ALL risk through replication, biomarker and 
genetic studies, for other exposures (i.e. iron, 
caffeine, pesticides/herbicides, paints and 
chemicals) the evidence base is much weaker. 
One reason for this is the lack of accurate 
exposure data available for such studies, as 
most often this is collected retrospectively and 
exposure measurements are often not 
optimal. Furthermore, given the relative rarity 
of the occurrence of ALL, estimating the effect 
of what could potentially be subtle changes in 
environmental exposure on risk is difficult as 
large numbers of cases are required to 
accurately assess the impact of such factors on 
disease risk. Therefore alternative approaches 
are required to strengthen the evidence for a 
role of environmental factors in risk of 
childhood ALL. As discussed, DNA methylation 
can be influenced by environmental exposures 
and is also aberrant in leukemic cells, and 
therefore may act as a mediator between 
environment and disease outcome, and as a 
secondary event in the multiple hit pathway to 
ALL (see Figure 2). The following sections 
summarise evidence from the current 
literature regarding environmental exposures 
and ALL risk and, to what extent these 
exposures have also been associated with 
variation in DNA methylation.  
 
Figure 2. Plausible causal pathway to acute lymphoblastic leukemia: an initial genetic abnormality, 
followed by an alteration in DNA methylation influenced by an environmental exposure. 
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Table 1. Literature providing evidence for positive and negative associations between 
environmental exposures and acute lymphoblastic leukemia risk. 
Environmental exposure Literature 
Pre-natal Exposures  
Smoking [35], [36] ,[37], [38], [39], [40], [41], [42], [43], 
[44], [45] 
Alcohol  [46], [36], [37], [47], [48], [49], [50], [51], [52], 
[53] 
Folic acid [54], [55], [41], [56], [53], [57], [58], [59], [60], 
[61], [62] 
Caffeine  [37], [63], [64], [65], [66], [43] 
Iron [67], [68], [69], [70], [71], [72] 
Pesticides and herbicides  [73], [74], [75], [76], [77], [78], [79], [80], [81], 
[81]  
Paints and chemicals (home/occupational use) [77], [82]    
Post-natal exposures 
Infection history [3], [83], [84], [85], [86], [87], [88], [89], [90] 
Childcare and day care attendance [3], [50], [85], [89], [88], [89], [91], [92], [93], 
[94], [95], [96], [97], [98], [99], [100], [101], 
[102], [103], [104], [105] 
Radiation [106], [107], [108] 
Breast feeding [89], [95], [106], [105] 
Birth weight   [89], [109], [110] 
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Pre-natal exposures 
Smoking 
The knowledge of the carcinogenic properties 
of cigarette smoke, with an estimated 7000 
chemicals affecting the body, led to studies to 
investigate the effect maternal smoking on ALL 
risk. Studies have offered conflicting evidence 
surrounding the association between ALL and 
prenatal/maternal smoking. John et al. [45] 
was one of the first studies to find an 
association between maternal smoking and 
ALL risk. A case-control study was used, and 
smoking data was attained by 1:1 interviews of 
parents from 223 cases of childhood cancer 
(diagnosed in Denver, Colorado 1976-1983). 
An increased risk of childhood cancer including 
ALL was observed in mothers who smoked 
during their first trimester of pregnancy. 
However subsequent studies have found no 
association between maternal smoking and 
ALL [36, 37, 43]. It is pertinent to indicate that 
most studies utilise data collected from 
telephone interviews, questionnaires and 1:1 
interviews with mothers.  A recent review 
confirmed the supposition of reporting bias on 
self-reported smoking [111]. Previous 
literature was systematically reviewed and 
trends of underestimation were shown when 
the evidence is based on self-reports 
compared to using biomarkers. A recent meta-
analysis investigated the association between 
childhood ALL and maternal smoking during 
pregnancy [44]. Data were analysed from 21 
individual studies conducted between 1999 
and 2014. An association between maternal 
smoking and ALL was found, but the authors 
were not able to evaluate the effect of 
quantiles of cigarettes used by the women 
during pregnancy.  
Associations have also been found between 
paternal smoking at home, parental smoking 
after birth, and number of smokers in the 
household and increased risk of ALL [39]. More 
recently, paternal smoking pre-conception 
reported through retrospective telephone 
questionnaires was found to be significantly 
associated with ALL [43]. These data were 
consistent with a previously published meta-
analysis which used data from 18 
epidemiological studies and analysed dose-
response relationship between ALL risk and 
smoking, finding associations with paternal 
smoking preconception and during pregnancy 
[112]. The possibility remains that this 
association may be confounded due to the 
concordance observed between maternal and 
paternal smoking, and thus the null 
associations observed between maternal 
smoking and ALL may be due to maternal self-
report bias. Conversely, evidence from animal 
models suggests that paternal environmental 
factors can influence the sperm epigenome 
and pregnancy outcome [113], and influence 
methylation patterns of the offspring [114, 
115], which may suggest that paternal, as well 
as maternal smoking may play a role in 
offspring ALL risk.   
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Whilst smoking clearly impacts DNA damage 
which is important in carcinogenesis, and 
therefore may influence risk of ALL [38], DNA 
methylation, which is also altered through 
smoking [35, 116], may be an additional 
mechanism involved in the causal pathway 
leading to ALL. The possible long-term effects 
that either maternal or paternal smoking may 
have on offspring DNA methylation patterns 
may lead to the development and progression 
of disease through altered gene expression.  
A large epigenome-wide association study 
(EWAS) recently investigated extensive 
genome-wide changes in DNA methylation in 
association with current, former and never 
tobacco smoking in the KORA cohort 
(Cooperative Health Research in the Region 
Augsburg) [116]. Significant site-specific 
differences were observed in each of the 22 
autosomes, identifying 187 CpG sites with 
differential methylation associated with 
smoking. Importantly it was also noted that 
even after participants stopped smoking there 
were still measured differences in methylation, 
showing the long term impact that smoking 
can have on DNA methylation [116]. Whilst this 
study does not measure the effects of smoking 
during pregnancy and possible effect on 
offspring, it demonstrates that the effect of 
tobacco smoking on DNA methylation is 
evident, even long after cessation.  
There is however evidence from the literature 
suggesting that maternal smoking can 
influence DNA methylation in offspring. 
Joubert et al. [35] used the 450k BeadChip to 
measure differential methylation related to 
maternal smoking during pregnancy in 1062 
newborn cord blood samples from the 
Norwegian Mother and Child Cohort Study 
(MoBa). Maternal plasma cotinine, an 
objective biomarker of smoking, was 
measured during pregnancy and related to 
offspring cord blood DNA methylation [35]. In 
addition, maternal self-report of smoking 
during pregnancy were also related to 
offspring methylation. Twenty-six CpGs 
mapped to 10 genes were found to be 
differentially methylated in association with 
maternal smoking, assessed by measuring 
plasma cotinine levels in cord blood. These 
included AHRR, CYP1A1, and RUNX1 (aka 
AML1).  AHRR and CYP1A1 are of particular 
interest as they encode proteins known to be 
involved in the detoxification of compounds 
from tobacco smoke (polycyclic aromatic 
hydrocarbons) [40]. AHRR codes for an 
evolutionary conserved bHLH-PAS (basic helix-
loop-helix/Per-AHR nuclear translocator 
(ARNT)-Sim) protein. This protein mediates 
toxicity via the aryl hydrocarbon receptor 
signal cascade; which is also responsible for 
regulation of cell growth, cell differentiation, 
and the modulation of the immune system 
[116]. Also of interest to this review, RUNX1 
which is involved in the development of 
normal haematopoiesis and leukemia. 
Differential methylation at the 26 CpG sites 
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found to be related to smoking in the discovery 
study (MoBa) were further investigated in a 
replication study (using maternal self-reports). 
The replication population which consisted of 
18 children born to smoking mothers and 18 
children born to non-smoking mothers from 
the United States Newborn Epigenetics STudy 
(NEST). Of the 26 CpGs measured, 21 were 
found to have altered methylation in 
association with maternal smoking in the 
replication cohort. In the same cohort (MoBa), 
Joubert et al. [42] also evaluated the impact of 
timing of the mothers smoking. A significant 
association was only found with sustained 
smoking exposure (through at least 18 weeks 
gestation). AHRR and RUNX1 were again 
highlighted as genes which had altered 
methylation due to smoking exposure. The 
most recent EWAS to date analysing the effect 
of smoking on DNA methylation observed 
dose-response associations for 15 CpG sites in 
seven genes (including previously mentioned 
AHRR and CYP1A1) in cord blood [117]. 
Longitudinal analysis of the effects of smoking 
on DNA methylation at age 7 and 17 years 
demonstrated that some CpG sites 
methylation changes were reversed, while 
others such as AHRR and CYP1A1 showed 
persistent altered patterns of methylation. 
This demonstrates that offspring methylation 
differences induced by prenatal smoking 
exposure persist during childhood, providing a 
potential mechanistic link between in utero 
exposure and later disease risk. 
Altered methylation has been documented in 
fetal liver samples (from elective terminations 
between 11-21 weeks gestation) from mothers 
who smoked compared to controls [118]. For 
accurate classification of smoking status 
cotinine concentrations were measured. DNA 
methylation was measured at a number of 
regions known to be important in controlling 
the insulin-like growth factor 2 (IGF2), which 
has been previously described as susceptible to 
the in utero environment. The male fetal liver 
samples showed an increase in DNA 
methylation at one CpG site within the H19 
Imprinting control region, whereas female 
fetal liver samples showed a decrease in 
methylation at multiple CpG sites within the 
IGF2 differentially methylation regions (DMR) 
associated with smoke exposure [118].  
Alcohol  
Studies have investigated the association 
between maternal alcohol drinking as a non-
genetic risk factor for ALL [36]. Alcohol is 
recognised as being carcinogenic for humans 
and can affect the fetus via ethanol crossing 
the placental barrier. Acetaldehyde has the 
ability to initiate mutagenic activity within the 
fetus and can be directly ingested through 
alcohol consumption by the mother or as a 
result of alcohol metabolism [49]. There is 
conflicting evidence with respect to the 
relationship of alcohol and ALL risk, some in 
support of an association [36, 37, 48], some 
reporting no association between alcohol and 
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ALL risk [49, 50]. In an early study, Petridou et 
al. [50] assessed the association between 
alcohol and childhood leukemia in a case-
control study comprising of 153 confirmed 
cases of childhood leukemia in Greece, with 
interviewer-administered questionnaires for 
exposure data collection. They found an 
inverse association with maternal alcohol 
consumption (small or moderate intake) and 
ALL. In another study, data collected via 
telephone interviews highlighted specific time 
frames of maternal alcohol intake were shown 
to increase the risk of ALL [36], with the 
susceptible period being in the second or third 
trimester of pregnancy. Menegaux et al. [37] 
carried out a multicentre case-control study 
(280 incident cases and 288 hospitalised 
controls) in which data were collected during 
1:1 interviews. Their study showed significant 
associations with alcoholic beverage 
consumption (wine, beer, spirits) during 
pregnancy and ALL, with a higher odds ratio for 
children diagnosed at less than two years of 
age. A review of data published on the effect of 
parental alcohol consumption and childhood 
cancer observed that roughly a third of the 
epidemiological evidence evaluated (published 
between 1982 and 2003) found at least one 
statistically significant risk increase in relation 
to parental drinking [48]. The first meta-
analysis investigating in utero exposure to 
alcohol and its relationship with ALL found no 
significant association, although this report 
was deemed inconclusive due to the lack of 
appropriate published data [49]. When 
interpreting this data we must consider the 
potential problems with the method of data 
collection used. Reporting bias may influence 
the accuracy of the data as the information 
regarding alcohol intake during pregnancy was 
collected retrospectively which may introduce 
recall bias. Furthermore, there is also the 
possibility of under reporting intake during 1:1 
or telephone interviews due to the stigma of 
alcohol drinking whilst pregnant.   
Interactions between alcohol consumption 
and maternal folate intake have been reported 
to influence ALL risk. Several associations 
between genetic variations of folate pathway 
genes and risk of ALL have been recorded, 
which varied depending on levels of maternal 
folate and alcohol intake [53]. This provides 
evidence for a possible cumulative effect; i.e. 
being exposed to multiple ALL associated 
environmental exposures could create a higher 
risk, further strengthening the hypothesis that 
ALL requires multiple ‘hits’ to reach full disease 
state.  
There is evidence from the literature to 
suggest that DNA methylation may be 
influenced by alcohol intake. A significant 
increase in DNA methylation was found in the 
HERP (homocysteine-induced endoplasmic 
reticulum protein) promoter in the blood of 
patients with alcohol dependence compared 
to controls. This was significantly associated 
with elevated homocysteine levels [51] (raised 
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homocysteine levels have been found in social 
drinkers [52]). Since elevated homocysteine 
concentrations can influence genomic and 
gene-specific DNA methylation in peripheral 
blood cells [119], the elevation of 
homocysteine may account for the observed 
associations between DNA methylation and 
alcohol intake. Therefore alcohol consumption 
may induce epigenetic modification via 
ethanol-related dysfunction to one carbon 
metabolism (OCM) [46]. Furthermore, 
neonatal exposure to ethanol in rats resulted 
in global disruptions in DNA methylation [120], 
suggesting that maternal alcohol intake may 
affect epigenetic programming of offspring. 
Although the mechanism by which alcohol-
induced methylation changes occur are 
unclear, one suggested pathway maybe via 
altered one-carbon metabolism. 
Folic acid  
Epidemiological studies have provided 
evidence of the importance of folic acid in the 
maternal diet for fetal development [121], and 
suggest that it may have a protective role 
against some childhood cancers [122]. The 
protective role of folate is considered to be due 
to its ability to influence DNA synthesis, repair 
and methylation through the OCM pathway 
[123]. 
There are a number of studies which support 
the protective effects of maternal folic acid 
supplementation [55, 57], and specifically for 
ALL [53, 56, 61]. One of the largest studies to 
date investigating maternal folic acid 
supplementation suggested that prenatal use 
of folic acid supplements reduces the risk of 
ALL [61]. Maternal supplementation data was 
obtained on 6963 ALL cases (and controls) 
from multiple case-control studies 
participating in the Childhood Leukemia 
International Consortium (CLIC). It was also 
acknowledged that the observed association 
varied by parental education which was used 
as a proxy for lifestyle and socio-demographic 
characteristics. Amigou et al. [56] also found 
that childhood acute leukemia was inversely 
associated with maternal folic acid 
supplements before and during pregnancy. 
Correlations between genetic polymorphisms 
of the folate metabolism pathway with ALL 
susceptibility were also investigated. A positive 
association with ALL was found with carriers of 
both MTRR variant alleles measured whilst 
being homozygous for any variant allele of the 
MTHFR polymorphisms measured. There have 
also been associations reported between 
childhood ALL and single SNPs found in CBS 
and TYMS, as well as haplotype blocks within 
CBS, MTHFD1, MTRR, and MTHFR, and 
haplotype blocks found just outside CBS and 
TYMS [53]. All of these genes code for enzymes 
or co-factors that are involved in the OCM 
pathway.  
Due to its important role in the biosynthesis of 
the universal methyl donor, S-
adenosylmethionine (SAM), altered folate 
intake has been associated with altered DNA 
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methylation. Indeed, DNA methylation has 
been reported to be decreased in cells grown 
in the absence of folate [54], and moderate 
restrictions in folate intake in human 
intervention studies displayed reduced 
genome-wide DNA methylation for women 
[58, 59]. Amarasekera et al. [60] specifically 
investigated the effect of folic acid on 
regulation of fetal DNA methylation. Folate 
status was measured in blood samples 
collected in the third trimester, and mothers 
were split into high folate (HF) and low folate 
(LF) groups. The DNA methylation profiles of 
the offspring were analysed in neonatal 
immune cells (CD4+ and antigen-presenting 
cells) to identify the effects of folic acid. Seven 
folate sensitive regions were found. 
Hypomethylation of a CpG dense region 
upstream of the ZFP57 was associated with HF. 
ZFP57 controls DNA methylation during early 
multicellular stages of development and is 
required to regulate and maintain imprinting 
of genes [60], and has also been suggested as 
a novel oncogene [124]. Interestingly, Silver et 
al. [62] found that season of conception in 
rural Gambia affected methylation at ZFP57, 
and identified the genomic region 
(approximately 3 kb upstream of ZFP57) as a 
potential metastable epiallele (ME). This points 
the effect that maternal nutrition, including 
folate, may have on systemic methylation in 
offspring.   
 
Caffeine  
Caffeine has been associated with the risk of 
low birth weight when consumed daily by 
pregnant women [63]. However, the 
relationship between maternal caffeine intake 
and ALL risk has not been extensively 
investigated, some studies suggest that 
increased caffeine consumption may increase 
ALL risk [64], whilst others found no 
association [50]. There are a number of 
possible mechanisms by which caffeine could 
increase ALL risk. Caffeine may act as an 
inhibitor for DNA topoisomerase II, DNA repair, 
or carcinogen metabolism [64]. Via the 
inhibition of these important cellular processes 
it could induce chromosomal aberrations and 
translocations, such as abnormalities of 
chromosome 11q23 which is one potential 
cause of ALL [64]. Caffeine may also increase 
ALL risk via alteration in DNA methylation.  
A recent meta-analysis carried out by Cheng et 
al. [64] investigating the risk of maternal coffee 
consumption and risk of childhood leukemia 
included; seven case-control studies, with a 
collective total of 2090 cases (AL, ALL, and 
AML) and 3630 controls. The odds ratio for 
maternal coffee intake increased linearly with 
the amount of coffee consumed daily; 
compared to non/lower drinkers (≤ 3 
cups/day) of coffee there was a 22% increased 
risk for ever drinkers (4-8 cups/day), and 72% 
increased risk for higher level coffee drinkers 
(<8 cups/day) and offspring acute leukemia. 
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Findings suggest a significant association 
between maternal coffee drinking and 
childhood ALL; this association has also been 
found in other studies [37]. 
Some evidence from animal model studies 
suggest maternal caffeine consumption can 
alter DNA methylation. Ping et al. [63] intra-
gastrically treated pregnant rats with caffeine 
from gestational day 11-20. Caffeine treatment 
enhanced the expression of DNMT1, DNMT3a, 
and DNMT3b genes responsible for 
methylating DNA. It was also associated with a 
notable increase in total methylation within 
the SF-1 promotor, as well as increased 
methylation frequency at single CpG sites 
within the SF-1 promotor. Buscariollo et al. 
[66] treated pregnant A1AR knockout mice 
with 20 mg/kg caffeine at embryonic day 8.5 
and identified altered DNA methylation 
patterns using DNA methylation arrays. An 
overall decreased methylation of 26% with 
7719 DMRs was observed in adult hearts of 
offspring exposed to caffeine during 
pregnancy. These data suggest that further 
investigations are warranted to understand 
the role of maternal caffeine consumption on 
offspring health in human studies.     
Iron  
Iron is an essential micronutrient required to 
maintain metabolic homeostasis and genome 
stability, it partakes in oxygen transport, 
mitochondrial respiration, and metabolising 
nucleic acids as well as being an antioxidant. 
Increased volemia and fetal requirement 
means pregnant women require more iron. 
The current recommended daily allowance 
(RDA) for pregnant women is 27mg/day. As for 
most nutrients, both iron deficiencies and 
overload are associated with health risks. Iron 
has the ability to damage biomolecules, which 
leads to the production of hydroxyl radicals 
and other reactive oxygen species (ROS). Iron 
possess the ability to induce a wide array of 
DNA lesions, from base modifications to strand 
breaks and adducts [67]. 
The hereditary hemochromatosis (HFE) gene 
has been identified as being associated with 
cancer susceptibility, including an increased 
risk of ALL [69, 72], and these findings have 
been replicated [71]. Polymorphisms of the 
HFE gene are now known to have correlations 
with altered iron status; C282Y polymorphisms 
impair β2-microglobulin association and cell 
surface expression of the HFE protein, H63D 
leads to a loss of ability to reduce transferrin 
receptor affinity for its ligand. The HFE C282Y 
polymorphism has previously been reported to 
elevate the risk for ALL [68]. In two 
independent groups of patients the C282Y 
mutation has been shown to be associated 
with altered ALL risk in males specifically [69], 
suggesting a gender-specific increased risk for 
haematological malignancies according to 
genotype. An association with HFE and ALL risk 
appears to be heightened through an 
interaction with a polymorphism in the 
transferrin receptor gene (TFRC). This 
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increased risk effect may be due to the 
biological interaction between HFE and TFRC 
genes, and iron transfer across membranes 
such as the placenta and intestinal mucosa 
[71].  
Although there is limited evidence, iron has 
been reported to have the ability to alter DNA 
methylation. Whilst iron 
accumulation/overload has been shown to 
induce DNA hypermethylation [67], a small 
positive association was found between LINE-1 
methylation levels in leukocyte DNA and 
chronic iron exposure measured in toenail 
clippings [125]. As there is currently very little 
evidence to support the relationship between 
iron and DNA methylation further 
investigations are warranted to better 
understand this possible interaction.  
Pesticides & herbicides 
Despite several pesticides and herbicides being 
classified as probably, possibly or carcinogenic 
to humans [126], we do not have a good 
understanding of any long-term health effects 
of exposures to such agents, particularly in 
pregnant women and their children. Past 
studies have revealed weak associations at 
best between the effects of herbicides and ALL 
risk [78]. However, over the last decade, a 
number of case control studies have shown 
positive associations with home/garden use of 
pesticides/herbicides and an increased ALL risk 
in children [73-77]. All studies reported 
relationships between exposure and ALL 
outcome, with some studies observing that 
timing of exposure was also important. 
Exposure to pesticides pre- pregnancy, during 
pregnancy and early childhood appeared to 
confer an increased risk of ALL compared with 
exposures later in life [78].  
Environment, home, school, and dietary intake 
are all possible forms of exposure to 
pesticides/herbicides for mothers and their 
children, making it hard to avoid exposure, as 
well as having implications for the 
measurement and evaluation of exposure [79]. 
Furthermore, for most studies data were 
collected through the use of self-reports which 
are subject to recall bias, as well as there being 
a lack of available information on the full range 
of potential active ingredients in products 
used. Rudant et al. [73] specifically 
investigated the effect of selection bias in 
previous studies of household exposure to 
pesticides, and found that even though 
selection bias was likely within these studies 
this still did not explain the positive correlation 
between the use of pesticides and increased 
risk of ALL. The Northern California Childhood 
Leukemia Study (NCCLS) used several different 
methods to overcome previous limitations by 
including: quality control of self-reports; a 
home pesticide inventory and linkage to the 
Environmental Protection Agency (to obtain 
active ingredients data); collection and analysis 
of home dust samples (~600); a geographical 
environmental database (agricultural 
pesticides); and large scale genotyping to 
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assess the role of genes in xenobiotic pathways 
(transport and metabolism of pesticides) [79]. 
Findings from a subset (162 leukemia patients 
and matched controls) of the NCCLS suggested 
an amplified risk of childhood leukemia when 
exposed to household pesticides, and further 
indicated that timing of exposure appeared to 
be important (during pregnancy and early 
childhood significantly increased risk) [78]. 
Although the evidence is limited, some animal 
models suggest that pesticide exposure may 
alter DNA methylation. An alteration in 
methylation patterns in the hypothalamus of 
rats was shown after exposure to the 
agricultural insecticide 
dichlorodiphenyltrichloroethane (DDT), 
whereby six CGIs were hypomethylated in DDT 
exposed rats compared to controls [127]. 
Furthermore, Desaulniers et al. [80] reported 
that offspring DNA methylation can be altered 
due to maternal exposure to pesticides. 
Pregnant rats were exposed to high doses of 
organochlorine pesticides (OCP), 
methylmercury chloride (MeHg) or 
polychlorinated biphenyls (PCB) and offspring 
livers were collected at postnatal day 29. Gene 
expression levels of DNMT1, DNMT3A, and 
DNMT3B were reduced with high doses of PCB, 
and for mRNA for DNMT1 and DNMT3B with 
high doses of MeHg. Pyrosequencing 
methylation analysis revealed that high doses 
of PCB and MeHg were also associated with 
decreased methylation of the p16 promoter 
region. 
Home & occupational use of chemicals & 
paints  
Evaluating the effect of household chemicals 
and paints used by parent’s pre- and 
postnatally encounters the same problems as 
estimating the exposure of pesticides and 
herbicides, with the potential for recall bias 
and insufficient data on active ingredients in 
products used. Despite these difficulties, some 
studies that have provided evidence of an 
association between the uses of household 
chemicals and paints, and an increased risk of 
ALL. Prolonged exposures such as occupational 
contact have been investigated pre- and 
postnatally [77]; with an increased risk of ALL 
observed in children whose fathers worked 
with spray paints whilst the mother was 
pregnant, as well as working with spray paints, 
chlorinated solvents, dyes/pigments, methyl 
ethyl ketone and cutting oil once the child was 
born [77]. Research findings vary, with some 
studies finding strong associations with 
postnatal exposure to paints, whilst others, 
such as solvent exposure, yield inconsistent 
results and warrant further investigation [82]. 
There is also evidence that paint exposure 
appears to be specifically related to the ALL 
subtype with t(12;21)TEL-AML1 translocations, 
although exactly how the exposure influences 
disease progression is still unclear [82].     
One study investigated the influence of several 
chemicals in relation to epigenetic regulation 
and established alterations in total DNA 
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methylation as well as at specific gene loci 
[128]. Chemicals investigated included 
bromodichloromethane, 
dibromochloromethane, chloroform, 
hydrazine, trichloroethylene, benzidine, 
trichloroacetic acid, and di(2-ethylhexyl) 
(DEHP). Points of departure (POD) for cancer 
incidence, and change in DNA methylation 
were studied in laboratory animals (mice, rats 
and hamsters). A high degree of correlation 
was found between POD for cancer incidence 
and DNA methylation changes following 
exposure to environmental chemical 
carcinogens [88]. The administration of DEHP 
to pregnant rats and subsequent analysis of 
male offspring exposed a notably vulnerable 
epigenome during early developmental 
periods. This study provides evidence which 
supports the theory that DNA methylation may 
mediate the influence of chemical exposures 
on later cancer development. It also offers a 
method of testing the potentially harmful 
effect of chemicals on the epigenome, which 
could lead to better guidelines for chemical 
use.     
Post-natal exposures 
Infection, the immune system, & breast 
feeding 
Infection was one of the first suggested risk 
factors for ALL [83]. There are currently two 
main infection-based hypotheses for ALL. The 
Kinlen population mixing hypothesis, which 
states that the association is due to unusual 
demographic mixing of susceptible and 
infected individuals, this happens perinatally 
and is probably caused by a single novel virus. 
Current evidence for this hypothesis is the 
transiently increased incidence of ALL in 
several situations of population mixing or 
clustering [3]. The Greaves delayed infection 
hypothesis, suggests that an abnormal 
immune response to delayed exposure to 
common infections in childhood due to a lack 
of early life exposure as infants increases risk 
of ALL. This hypothesis is supported by studies 
providing evidence that there is a reduced risk 
of ALL associated with day care attendance [3].    
Greaves hypothesis concentrates on the 
importance of timing of exposure rather than 
focusing on specific agents as suggested by the 
Kinlen hypothesis [84]. Children with a delayed 
or reduced exposure to common infections at 
an early age will develop a less adaptive 
immune system. This could lead to an 
increased cell proliferation when later 
confronted with a common infection, thus an 
increased risk of a second mutation and the 
development of ALL [85]. The United Kingdom 
Childhood Cancer Study (UKCCS) findings 
support this hypothesis, showing that a 
dysregulated immune response to infection in 
the first few months of life promotes 
progression to ALL disease later in childhood. A 
higher frequency of clinically diagnosed 
infectious episodes was also found to be 
correlated to an earlier onset of ALL [90]. 
Breast feeding is another proxy of early 
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stimulation of the immune system, promoting 
adequate maturation of the immune system in 
infants, and has also been inversely associated 
with ALL [89].   
The effect of infections on their hosts 
epigenetic landscape is becoming more widely 
discussed; with bacterial [129], and viral 
infections [130-132], being shown to alter the 
epigenetics of infected cells. The Epstein-Barr 
virus (EBV) has already been associated with 
multiple human malignancies, as well as being 
shown to have been of high incidence in 
paediatric ALL patients [133]. This virus can 
cause lifelong infection of resident epithelial 
and B-cells, resulting in a distinct pattern of 
EBV gene expression in infected cells which is 
regulated via epigenetic modifications [132]. 
The epigenetic effect of EBV has been analysed 
in an immortalized keratinocyte cell line. 
Global DNA methylation analysis showed over 
13000 differentially methylated CpG sites 
compared to controls, from this 65 genes 
which acquired methylation presented altered 
transcript levels. Birdwell et al. [132] suggested 
that the EBV virus may leave a lasting 
epigenetic imprint that could enhance the 
tumorigenic phenotype of infected cells. 
Parvovirus B19 (PVB19) has previously been 
associated will ALL [131], and a link between 
PVB19, DNA methylation and ALL has now also 
been observed. Bone marrow samples of B-cell 
ALL taken at diagnosis were serologically 
tested, revealing that samples were positive 
for PVB19 IgM and IgG. DNA methylation was 
found to be associated with a history of PVB19 
infection, indicated by IgG (p=0.02). This may 
cause increased leukaemogenic potential in 
susceptible B-precursor cells via PVB19 driven 
epigenetic alterations [131].  
Childcare & day care attendance  
Since Greaves hypothesised that delayed 
exposure to common infections leads to an 
increased risk of ALL, a number of studies have 
attempted to provide evidence for this 
hypothesis including analysis of time spent in 
day care at a young age, and thus exposure 
time to common infections in relation to ALL 
onset [3]. Theoretically, attendance of day care 
at a young age should mean that a child is 
confronted with common infections at an early 
age. This would allow them to build a more 
sophisticated immune system and reduce the 
chances of an increased proliferation and risk 
of mutation if confronted with common 
infections at a later date [85]. A large body of 
evidence suggests that there is a connection 
between early or increased day care 
attendance and a reduction in the risk of ALL 
[50, 91-104].  
A recent study using the findings from the 
NCCLS evaluated a summarised measure of 
“child-hours of exposure”, allowing them to 
capture the variance which can be contributed 
by individual day care variables [85]. Non-
Hispanic white children who attended more 
than 5000 day care hours during infancy 
compared to children who did not attend day 
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care had a reduced risk of ALL [85]. Children 
had a 58% reduced risk for ALL (95% 
confidence interval (CI): 0.18-0.99) and a 67% 
reduced risk for precursor-B ALL (Burkitt’s 
lymphoma/leukemia) (95% CI: 0.11-1.01). The 
trend was also observed, supporting the 
theory that there is a dose-response 
relationship. Also, as Greaves suggested, 
timing is important and reduction of risk was 
associated with attending day care during 
infancy, showing the importance of early life 
exposure [3]. 
When considering the effect childcare and day 
care attendance may have on DNA methylation 
one must first consider the Greaves delayed 
infection hypotheses [3], i.e. that childcare and 
day care attendance act as a proxy for 
exposure to infection. This appears to provide 
a protective effect against ALL, with timing and 
number of hours of care also effecting the risk. 
On the other hand as mentioned in the 
previous section infection also appears to 
increase the risk of ALL. It may be that more 
serious infections have the ability to influence 
the child’s epigenome (discussed above) [131]. 
Consequently delayed or limited childcare and 
day care attendance could leave a child’s 
immune system insufficiently matured and 
more susceptible to more serious infections. 
Radiation 
Potential cancer risk for children exposed to 
radiation is much higher than in adults as they 
are more radio sensitive [106]. A retrospective 
study found a positive association between 
radiation dose from CT scans and leukemia, 
with an almost triple risk of leukemia when 
children had cumulative doses of roughly 50 
mGy [106]. Furthermore, whilst radiotherapy 
treatment has contributed to the improved 
survival rates of childhood cancer over recent 
decades (30% to 80%) [107], an investigation 
into secondary malignant neoplasm (SMN) 
occurrences post-radiotherapy in children and 
adults revealed leukemia as one of the most 
prevalent SMNs [108].  
Radiation has been observed to induce 
changes in DNA methylation and there is 
evidence to suggest that this may lead to an 
altered cell response to subsequent radiation 
exposure [134]. In nuclear power plant 
workers, low dose radiation was associated 
with DNA methylation levels [90] whereby 
LINE-1 methylation levels were higher in 
radiation exposed-workers than controls. 
Associations between chromosome 
aberrations and radiation-induced DNA 
methylation were also suggested. 
Birth weight  
The association between birth weight and 
childhood cancer was originally suggested by 
MacMahon and Newill over 50 years ago [109]. 
Paltiel et al. [110] pooled data from six cohorts 
to investigate cancer incidence in relation to 
infant and parental characteristics, reporting a 
26% increased risk of childhood cancer 
(including ALL) for every kilogram increment in 
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birth weight. No association was found with 
prenatal overweight or pregnancy weight gain, 
suggesting that the component of childhood 
ALL risk explained by higher birth weight is not 
a consequence of maternal overweight or 
obesity but likely due to another pathway 
leading to fetal (over) growth. 
The first large EWAS investigating the 
relationship between birth weight and 
methylation revealed methylation at 19 CpG 
sites to be associated with birth weight. Some 
of the identified CpG sites were located within 
genes responsible for adipogenesis and DNA 
repair [135]. A more recent study confirmed 
two CpG sites identified in the MoBa cohort as 
well as a further 21 CpG sites, were associated 
with birth weight [136]. Both studies found 
that several of their birthweight related CpG 
sites were linked to genes which played an 
important role in development. Simpkin et al. 
[136], also acknowledged that the effect of 
birth weight on methylation was predominant 
in cord blood, and this highlights a potential 
critical window for the effects of pre-natal and 
early life exposures on DNA methylation, 
which may impact on future disease risk.   
Conclusion 
ALL is the most common cancer in children 
[34], but the causes of this disease are still 
largely unknown. However, a growing amount 
of literature now supports the contribution of 
various environmental factors to risk of ALL 
development. Roughly 80% of cases are of 
precursor-B cell origin (CD19+, CD10+), and the 
incidence of this specific immuno-phenotype 
has increased in the Western world over the 
past several decades [34]. This increase may be 
due to changes in exposures pregnant women 
and young children are confronted with in 
modern everyday life. Indeed, this review 
suggests that there are a number of 
environmental exposures which increase the 
risk of ALL, and therefore warrant further 
investigation. Although survival rates have 
improved dramatically over the past few 
decades ALL survival is associated with a 
greatly increased ill health in adulthood [137]. 
This is due to the impact of treatment, thus 
prevention strategies are desirable. Therefore 
understanding exactly how the exposures 
discussed in this review are increasing the 
chance of ALL will be critical in understanding 
the causal pathway to disease. Furthermore, 
this will provide potential predictive disease 
biomarkers and plausibly may help determine 
appropriate and effective preventative 
intervention strategies.  
As an epigenetic modification, DNA 
methylation, which plays a crucial role in 
forming cellular identity by influencing gene 
expression, is likely to be involved in the causal 
disease pathway of ALL. Indeed, there is a body 
of evidence to indicate that DNA methylation 
is altered in childhood ALL [1, 14, 138-140], but 
knowledge of how these alterations occur and 
if they could be prevented will be important in 
improving understanding of the underlying 
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mechanisms of the disease. Furthermore, since 
DNA methylation patterns can be 
environmentally orchestrated, knowledge of 
the involvement of this mechanism in disease 
aetiology may provide plausible and 
implementable intervention strategies for high 
risk individuals such as those with Down’s 
syndrome or Fanconi Anaemia. Here we have 
explored the supposition that environmental 
exposures associated with ALL risk have the 
potential to alter DNA methylation thus 
making DNA methylation a plausible mediator 
of environmental influences in the 
pathogenesis of ALL. We have reviewed 
evidence in support of this hypothesis, and 
conclude that evidence from the literature 
could suggest that several environmental 
exposures associated with increased childhood 
ALL risk i.e. alcohol, smoking, and folate are 
able to alter DNA methylation and therefore 
this may be one mechanism by which these 
exposures are involved in the causal pathway 
to disease. AHRR and CYP1A1 are the two 
clearest genes which exhibit methylation 
change due to an environmental exposure 
(smoking), and have similarly been shown to 
be frequently abnormally methylated in ALL 
[1]. The review of the literature and crossover 
between aberrant methylation in response to 
environmental factors and in ALL is not 
exhaustive in the context of this review. 
Further rigorous investigation of the available 
data is required to explore further connexions, 
these examples add weight to the hypothesis 
that DNA methylation may act as a mediating 
mechanism in this context. Further 
consideration should be given to the likelihood 
of a cumulative effect of exposures, whereby 
exposure to multiple ALL risk associated 
factors could further increase the chance of 
disease development through cumulative 
epigenetic aberrations. Further research is 
therefore warranted to investigate this 
hypothesis in order to aid understanding of the 
causal pathway to disease, which is vital in 
facilitating new treatments, initiating 
preventative strategies and screening for 
disease. 
Future perspectives 
To understand the pathway from the initial 
genetic ‘hit’ to a child being diagnosed with 
ALL, future studies will need to combine 
multiple investigations towards realisation of 
the multifactorial aetiology of ALL. The 
literature examined in this review provides 
evidence for a potential role of DNA 
methylation in ALL development through 
environmental exposures. Given the rarity of 
childhood cancers, the availability of robust 
exposure data and patient samples prior to 
diagnosis is limited, multiple complementing 
strategies will be required to further explore 
this concept. Initially, clearer evidence is 
required to show that ALL-associated risk 
exposures result in disease-associated DNA 
methylation changes. Global DNA methylation 
alterations seen in ALL are mostly seen across 
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all subtypes [1], and thus appear to be early 
events in ALL development. However, the 
importance of these methylation changes in 
inducing or contributing to disease 
development is less clear. As environmental 
exposures can potentially drive these changes 
in methylation it is important to understand if 
these changes can in turn drive ALL 
pathogenesis. Confirmation of the 
establishment of aberrant methylation 
patterns in ALL patients prior to diagnosis will 
be important in determining the role of these 
events in the causal pathway, however such 
studies may be challenging given the lack of 
biological material available. The utilisation of 
neonatal blood spot samples or collective 
cases from multiple large cohort studies may 
be feasible avenues of pursuit for case-control 
studies in this area. However, whilst this may 
establish proof of aberrant methylation prior 
to diagnosis, such studies are likely to be 
unable (through lack of data) or underpowered 
to detect changes in methylation associated 
with environmental factors which may be 
associated with disease outcome. In addition 
to using the ‘meet in the middle’ approach 
[141] to link early initiating epigenetic events 
in disease to environment, Mendelian 
randomisation approaches utilising genetic 
instruments as proxy markers for environment 
[142], will be key where environmental data is 
lacking but genetic material or data are 
available. Data from these combined 
approaches would further support the 
evidence that environmental factors are 
drivers in disease progression, and provide a 
mechanism by which they are part of the 
multiple hit pathway for ALL development. 
Such findings may provide predictive disease 
biomarkers and offer insights into how 
preventative strategies may be introduced.  
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Executive summary 
DNA methylation & acute lymphoblastic leukemia  
 Altered DNA methylation has been observed between acute lymphoblastic leukemia (ALL) 
cells and nonleukemic bone marrow, and as well as between ALL subtypes.  
 Nine thousand four hundred and six CpG sites were found to be predominantly 
hypermethylated across all subtypes in a large scale epigenome-wide association study of 
ALL cells compared to controls, demonstrating a genome wide disruption of the 
epigenome. 
Environmental exposures relationship with DNA methylation & ALL risk 
 Environmental exposures have been associated with an increased risk of ALL. 
 Currently there is fairly strong evidence supporting the association with exposures such as 
day care attendance, radiation, folic acid, smoking, and alcohol.  
 There is also evidence, although weaker for other exposures associated with ALL risk, in 
other words, iron, caffeine, pesticides/herbicides, paints and chemicals. 
 There is a growing amount of supporting evidence for alterations in methylation caused 
due to environmental exposures that are also linked to ALL risk, especially for smoking, 
folic acid and infection.  
Future perspectives 
 Further studies are warranted in order to support and strengthen the evidence for a 
potential mediating role of DNA methylation between risk exposures and ALL 
development. Multiple integrated and complementing strategies, in other words, ‘meet in 
the middle’ approaches will be required to provide evidence of this concept.  
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